Debt to EBITDA ratio Analysis of Tango Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of TNGX
Dec-23-0.0213Very Poor Debt to EBITDA | Dec-22-0.0166Very Poor Debt to EBITDA | Growth-28.27% |
Debt to EBITDA Analysis of Tango Therapeutics Inc
| Debt to EBITDA Ratio of TNGX drastically fell by -28.27 % this year. |
| Debt to EBITDA Ratio with value of 0 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -8.25 was lowest in Year Dec-20 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.0213 is Greater than Average Debt to EBITDA of -1.66 in last five years. |
Other Debt to EBITDA Related Info of TNGX that may interest you.
Tango Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| TNGX | 8.93 | 8.39 | 6.44 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of Tango Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| Debt to EBITDA | -0.0213 | -0.0166 | -0.0257 | -8.25 | 0 |
| Change | -28.27 % | 35.29 % | 99.69 % |
FY Chart of Debt to EBITDA of Tango Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)